We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYL icon
76
Tyler Technologies
TYL
$15.1B
$20.6M 0.43%
235,301
+11,015
+5% +$848K
USB icon
77
US Bancorp
USB
$97.2B
$20.4M 0.42%
557,203
-6,952
-1% -$257K
ROK icon
78
Rockwell Automation
ROK
$48.1B
$19.8M 0.41%
185,016
-3,145
-2% -$307K
AWK icon
79
American Water Works
AWK
$27.2B
$19.5M 0.41%
473,435
-444,684
-48% -$18.4M
MKTX icon
80
MarketAxess Holdings
MKTX
$5.72B
$18.5M 0.38%
308,161
+300,396
+3,869% +$16.1M
PLKI
81
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$18.1M 0.38%
415,875
+351,600
+547% +$14M
LAD icon
82
Lithia Motors
LAD
$8.16B
$17M 0.35%
233,204
+19,578
+9% +$1.28M
PX
83
DELISTED
Praxair Inc
PX
$16.3M 0.34%
135,630
-442
-0.3% -$52.5K
CAB
84
DELISTED
Cabela's Inc
CAB
$15.9M 0.33%
252,509
-129,036
-34% -$8.61M
BMRN icon
85
BioMarin Pharmaceuticals
BMRN
$12.6B
$15.3M 0.32%
212,126
+195,946
+1,211% +$13M
CSOD
86
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$14.8M 0.31%
288,466
+279,126
+2,989% +$13.8M
ETP
87
DELISTED
Energy Transfer Partners, L.P.
ETP
$14.2M 0.29%
427,124
+13,122
+3% +$419K
AAPL icon
88
Apple
AAPL
$4.59T
$13.9M 0.29%
817,992
-53,536
-6% -$888K
MON
89
DELISTED
Monsanto Co
MON
$11.3M 0.23%
107,811
-628,382
-85% -$63.1M
MELI icon
90
Mercado Libre
MELI
$97.9B
$10.4M 0.22%
76,926
-203,175
-73% -$24.4M
CLB icon
91
Core Laboratories
CLB
$564M
$9.88M 0.21%
58,390
+19,409
+50% +$3.01M
GME icon
92
GameStop
GME
$8.19B
$9.79M 0.2%
+788,812
New +$9.43M
EBAY icon
93
eBay
EBAY
$45.5B
$9.55M 0.2%
406,795
-1,037,573
-72% -$23.3M
SIX
94
DELISTED
Six Flags Entertainment Corp.
SIX
$9.44M 0.2%
+279,310
New +$9.88M
PARA
95
DELISTED
Paramount Global Class B
PARA
$9.24M 0.19%
167,590
+35,645
+27% +$1.9M
PCP
96
DELISTED
PRECISION CASTPARTS CORP
PCP
$8.9M 0.18%
39,176
-915
-2% -$206K
OKE icon
97
Oneok
OKE
$59.7B
$8.81M 0.18%
188,787
+2,771
+1% +$120K
VRSK icon
98
Verisk Analytics
VRSK
$24.9B
$8.78M 0.18%
135,170
+30,905
+30% +$1.95M
CB icon
99
Chubb
CB
$131B
$8.72M 0.18%
93,222
+8,436
+10% +$771K
BIDU icon
100
Baidu
BIDU
$32.9B
$7.1M 0.15%
45,755
+32,509
+245% +$4.19M

Similar funds

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.